There isn’t a single “best” medication for a COPD flare-up. Flare-ups (also called exacerbations) are treated with a combination of three types of medication: fast-acting inhalers to open the airways, a short course of oral steroids to reduce inflammation, and sometimes antibiotics if infection is involved. The specific combination depends on how severe the flare-up is and what triggered it.
Fast-Acting Inhalers Are the First Step
The first medication you’ll reach for during a flare-up is a short-acting bronchodilator, most commonly albuterol. This is a rescue inhaler that relaxes the muscles around your airways within minutes, making it easier to breathe. If albuterol alone isn’t enough, your doctor may add a second type of fast-acting inhaler (a short-acting muscarinic antagonist like ipratropium) that works through a different mechanism to open the airways further.
During a flare-up, you’ll use these inhalers more frequently than usual. GOLD guidelines suggest taking one or two puffs every hour for the first two or three doses, then spacing them out to every two to four hours based on how you’re responding. As your breathing improves, you can gradually extend the time between doses.
Nebulizer vs. Inhaler With Spacer
Many people assume a nebulizer works better than a handheld inhaler during a flare-up, but the evidence doesn’t support that. A Cochrane review found no meaningful difference in lung function, breathlessness, hospital admission rates, or length of hospital stay between the two delivery methods. If you can coordinate your breathing well enough to use a metered-dose inhaler with a spacer, it works just as well. Nebulizers are mainly useful when you’re too breathless or weak to use an inhaler effectively.
Oral Steroids to Control Inflammation
For moderate to severe flare-ups, oral corticosteroids are a cornerstone of treatment. They work by rapidly reducing the inflammation and swelling inside your airways that makes breathing so difficult during a flare. The typical regimen is 30 mg of prednisolone per day.
Guidelines traditionally recommended 7 to 14 days of steroids, but a landmark trial (the REDUCE trial) found that a 5-day course was just as effective as 14 days at preventing another flare-up. This shorter course has become increasingly standard because it delivers the same benefit with fewer steroid side effects like sleep disruption, mood changes, elevated blood sugar, and appetite increases. If your doctor prescribes a longer course, it may be worth discussing whether a shorter one is appropriate for your situation.
When Antibiotics Are Needed
Not every COPD flare-up requires antibiotics. They’re only helpful when a bacterial infection is driving the flare, and doctors use three key signs to make that call: increased breathlessness, producing more mucus than usual, and a change in mucus color (from clear or white to yellow, green, or brown). When at least two of these symptoms are present, particularly if your mucus has changed color, antibiotics are typically prescribed.
The choice of antibiotic varies. Commonly used options include amoxicillin-clavulanic acid, azithromycin, doxycycline, and certain fluoroquinolones. A network analysis comparing 17 different antibiotics found that several performed well, but the best choice depends on local resistance patterns, your allergy history, and whether you’ve taken antibiotics recently. Your doctor will factor all of this in when prescribing.
How Flare-Up Severity Changes Treatment
The medications you receive depend heavily on how bad the flare-up is. Flare-ups are classified into three levels after the fact, based on what treatment was needed:
- Mild: Managed at home by increasing your rescue inhaler use. No steroids or antibiotics needed.
- Moderate: Requires a course of oral steroids, antibiotics, or both, but you can still be treated as an outpatient.
- Severe: Requires hospitalization. You may receive intravenous steroids, continuous monitoring, and supplemental oxygen.
If you’re hospitalized, oxygen therapy is carefully controlled. The target oxygen saturation for COPD patients is 88% to 92%, which is lower than you might expect. Research shows that inpatient mortality is lowest in this range. Even modest elevations above it (93% to 96%) are associated with increased risk of death, because too much supplemental oxygen can cause dangerous carbon dioxide buildup in people with COPD. If blood tests confirm your carbon dioxide levels are normal, the target may be adjusted upward to 94% to 98%.
In the most severe cases, when medications and oxygen aren’t enough to stabilize breathing, non-invasive ventilation (a pressurized mask that helps push air into your lungs) may be used. This is reserved for situations where blood acidity and carbon dioxide levels reach critical thresholds despite standard treatment.
Preventing the Next Flare-Up
If you’re experiencing frequent flare-ups (two or more per year), your doctor may recommend a low-dose antibiotic taken regularly to reduce the frequency. The most studied approach is azithromycin at 250 mg daily, or 250 to 500 mg three times per week. This isn’t treating an active infection. Instead, azithromycin has anti-inflammatory properties that help calm the airways over time. This strategy isn’t for everyone, as long-term antibiotic use carries risks including hearing changes and antibiotic resistance, but for people with frequent flare-ups it can meaningfully reduce how often they occur.
Beyond prophylactic antibiotics, the most effective prevention is optimizing your daily maintenance medications. Staying consistent with long-acting inhalers, attending pulmonary rehabilitation, getting annual flu and pneumonia vaccines, and having a written action plan so you know exactly when to start rescue treatment all reduce the likelihood and severity of your next flare-up.